Study highlights the link between urinary and vaginal pathogenic E. coli in recurrent cystitis

FDA Com­mis­sion­er Rob Califf and bi­o­log­ics di­rec­tor Pe­ter Marks took to JA­MA on Fri­day to counter the cur­rent “large vol­ume” of vac­cine mis­in­for­ma­tion by urg­ing

The revenue for Rebisufligene Etisparvovec is expected to reach an annual total of $102 mn by 2038 globally based off GlobalData’s Expiry Model. The drug’s

Eli Lil­ly said its rev­enues in the sec­ond quar­ter jumped 28% year-over-year due to growth from its type 2 di­a­betes drug Moun­jaro, breast can­cer treat­ment